Last updated: June 13, 2025
Sponsor: Izmir Bakircay University
Overall Status: Active - Recruiting
Phase
N/A
Condition
Dyskinesias
Treatment
Turkish version of the Parkinson's Disease Dyskinesia Scale (PDYS-26)
Clinical Study ID
NCT07023224
IZBU-FTR-ITB-01
All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Being diagnosed with idiopathic Parkinson's disease
H&Y stage 1-3
UPDRS dyskinesia item score ≥1
Accepting to participate in the study
Exclusion
Exclusion Criteria:
Diagnosis of atypical-secondary parkinsonism
Severe musculoskeletal, neurological and/or cardiopulmonary problems that may affectthe results of the assessment
Mini Mental State Examination score < 24
Study Design
Total Participants: 130
Treatment Group(s): 1
Primary Treatment: Turkish version of the Parkinson's Disease Dyskinesia Scale (PDYS-26)
Phase:
Study Start date:
November 14, 2024
Estimated Completion Date:
August 31, 2025
Study Description
Connect with a study center
Izmir Bakırçay Univercity
İzmir, 35000
TurkeyActive - Recruiting
Bakirçay University Çiğli Regional Education Hospital
İ̇zmi̇r, 35000
TurkeyActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.